B-lineage transcription factors and cooperating gene lesions required for leukemia development

Differentiation of hematopoietic stem cells into B lymphocytes requires the concerted action of specific transcription factors, such as RUNX1, IKZF1, E2A, EBF1 and PAX5. As key determinants of normal B-cell development, B-lineage transcription factors are frequently deregulated in hematological malignancies, such as B-cell precursor acute lymphoblastic leukemia (BCP-ALL), and affected by either chromosomal translocations, gene deletions or point mutations. However, genetic aberrations in this developmental pathway are generally insufficient to induce BCP-ALL, and often complemented by genetic defects in cytokine receptors and tyrosine kinases (IL-7Rα, CRLF2, JAK2 and c-ABL1), transcriptional cofactors (TBL1XR1, CBP and BTG1), as well as the regulatory pathways that mediate cell-cycle control (pRB and INK4A/B). Here we provide a detailed overview of the genetic pathways that interact with these B-lineage specification factors, and describe how mutations affecting these master regulators together with cooperating lesions drive leukemia development.

[1]  M. Atchison,et al.  BSAP Can Repress Enhancer Activity by Targeting PU.1 Function , 2000, Molecular and Cellular Biology.

[2]  R. Grosschedl,et al.  Failure of B-cell differentiation in mice lacking the transcription factor EBF , 1995, Nature.

[3]  D. Kioussis,et al.  TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. , 2004, Blood.

[4]  S. Boggs,et al.  Lack of Natural Killer Cell Precursors in Fetal Liver of Ikaros Knockout Mutant Mice , 1999, Natural Immunity.

[5]  J. Hehir-Kwa,et al.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression , 2007, Leukemia.

[6]  A. Friedman,et al.  Phosphorylation of RUNX1 by Cyclin-dependent Kinase Reduces Direct Interaction with HDAC1 and HDAC3* , 2010, The Journal of Biological Chemistry.

[7]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[8]  T. Ikawa,et al.  Runx 1 – Cbf facilitates early B lymphocyte development by regulating expression of Ebf 1 , 2012 .

[9]  Philippe Kastner,et al.  Ikaros is critical for B cell differentiation and function , 2002, European journal of immunology.

[10]  G. Sauvageau,et al.  High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. , 2005, Genes & development.

[11]  S. Pileri,et al.  PAX5 Expression in Acute Leukemias , 2004, Cancer Research.

[12]  Manfred Lehner,et al.  Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell Development , 2008, Cell.

[13]  E. Thiel,et al.  Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG , 2011, Oncogene.

[14]  D. Kioussis,et al.  TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL , 2007, Oncogene.

[15]  A. Look,et al.  SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. , 1999, Molecular cell.

[16]  R. Kuiper,et al.  The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution , 2012, PLoS genetics.

[17]  Maria Novatchkova,et al.  The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells. , 2011, Immunity.

[18]  M. Mandal,et al.  Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression , 2010, Molecular and Cellular Biology.

[19]  M. Busslinger,et al.  Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. , 2001, Immunity.

[20]  K. Garrett,et al.  Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. , 2005, Immunity.

[21]  J. D. Vos,et al.  PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study , 2009, Leukemia.

[22]  F. Sigaux,et al.  Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia , 2010, Leukemia.

[23]  E. Munthe,et al.  beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells. , 2009, Experimental hematology.

[24]  F. Buchholz,et al.  AML1 deletion in adult mice causes splenomegaly and lymphomas , 2006, Oncogene.

[25]  C. Cotta,et al.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage , 2003, The EMBO journal.

[26]  A. Sharpe,et al.  The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.

[27]  C. Pui,et al.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Busslinger,et al.  Independent regulation of the two Pax5 alleles during B-cell development , 1999, Nature Genetics.

[29]  J. Herman,et al.  Epigenetic inactivation of secreted Frizzled‐related proteins in acute myeloid leukaemia , 2008, British journal of haematology.

[30]  Kevin K Dobbin,et al.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. , 2010, Blood.

[31]  G. Smyth,et al.  Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice. , 2011, Blood.

[32]  E. Liu,et al.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. , 2012, Genes & development.

[33]  Berthold Göttgens,et al.  ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer. , 2011, Blood.

[34]  G. Salles,et al.  Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin , 2007, Leukemia.

[35]  Andrea Califano,et al.  Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL , 2011, Nature Medicine.

[36]  Ching-Hon Pui,et al.  Germline genomic variants associated with childhood acute lymphoblastic leukemia , 2009, Nature Genetics.

[37]  Zhihong Yu,et al.  Histone Acetyltransferase p300 Acetylates Pax5 and Strongly Enhances Pax5-mediated Transcriptional Activity* , 2011, The Journal of Biological Chemistry.

[38]  M. Gariboldi,et al.  ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells , 2011, PloS one.

[39]  J. Hagman,et al.  Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage , 2009, Proceedings of the National Academy of Sciences.

[40]  A. Sharpe,et al.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. , 1996, Immunity.

[41]  山口 祐子.  AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues , 2004 .

[42]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[43]  M. Busslinger,et al.  Essential functions of Pax-5 (BSAP) in pro-B cell development. , 1997, Immunobiology.

[44]  T. Kadesch,et al.  Phosphorylation of E47 as a potential determinant of B-cell-specific activity , 1996, Molecular and cellular biology.

[45]  M. Ohki,et al.  Activation of AML1‐mediated transcription by MOZ and inhibition by the MOZ–CBP fusion protein , 2001, The EMBO journal.

[46]  A. Feeney,et al.  Both E12 and E47 allow commitment to the B cell lineage. , 1997, Immunity.

[47]  A. Schambach,et al.  LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia , 2006, Nature Medicine.

[48]  J. Biggs,et al.  AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex , 2006, Molecular and Cellular Biology.

[49]  R Grosschedl,et al.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.

[50]  J. Downing,et al.  The E2A-HLF Oncoprotein ActivatesGroucho-Related Genes and SuppressesRunx1 , 2001, Molecular and Cellular Biology.

[51]  P. Kastner,et al.  Role of Ikaros in T-cell acute lymphoblastic leukemia. , 2011, World journal of biological chemistry.

[52]  K. Anderson,et al.  Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes. , 2007, Blood.

[53]  N. Speck,et al.  Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma. , 2004, Blood.

[54]  M. Baudis,et al.  ABCB1 over‐expression and drug‐efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A‐HLF expression , 2006, Pediatric blood & cancer.

[55]  C. Allis,et al.  Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. , 2008, Genes & development.

[56]  C. Murre,et al.  E-proteins directly regulate expression of activation-induced deaminase in mature B cells , 2003, Nature Immunology.

[57]  Elin Axelsson,et al.  Essential role of EBF1 in the generation and function of distinct mature B cell types , 2012, The Journal of experimental medicine.

[58]  M. Merkenschlager.  Ikaros in immune receptor signaling, lymphocyte differentiation, and function , 2010, FEBS letters.

[59]  Ian Krop,et al.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements , 1994, Cell.

[60]  M. Cazzola,et al.  Deletions of the transcription factor Ikaros in myeloproliferative neoplasms , 2010, Leukemia.

[61]  Y. Hayashi,et al.  TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease , 2005, Leukemia & lymphoma.

[62]  Donna Neuberg,et al.  Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. , 2010, Blood.

[63]  M. Loh,et al.  Advances in the Genetics of High-Risk Childhood B-Progenitor Acute Lymphoblastic Leukemia and Juvenile Myelomonocytic Leukemia: Implications for Therapy , 2012, Clinical Cancer Research.

[64]  S. Richards,et al.  Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome , 2003, Leukemia.

[65]  Elizabeth A. Kruse,et al.  The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells , 2008, Nature Immunology.

[66]  A. Berk,et al.  Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions , 2011, Oncogene.

[67]  E. Thiel,et al.  Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. , 2011, Blood.

[68]  James R. Downing,et al.  Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.

[69]  G. Jiménez,et al.  Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family , 2000, The EMBO journal.

[70]  P. Kastner,et al.  Ikaros in B cell development and function. , 2011, World journal of biological chemistry.

[71]  Markus Jaritz,et al.  The transcription factor Pax5 regulates its target genes by recruiting chromatin‐modifying proteins in committed B cells , 2011, The EMBO journal.

[72]  C. Klemke,et al.  Genomic loss of the putative tumor suppressor gene E2A in human lymphoma , 2011, The Journal of experimental medicine.

[73]  H. Weintraub,et al.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB , 1996, Molecular and cellular biology.

[74]  Lionel O Mavoungou,et al.  Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation , 2011, Nucleic acids research.

[75]  R. Bronson,et al.  Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[76]  S. Berger,et al.  A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. , 1999, Molecular cell.

[77]  Katie L. Kathrein,et al.  Ikaros Induces Quiescence and T-Cell Differentiation in a Leukemia Cell Line , 2005, Molecular and Cellular Biology.

[78]  Alfred L. Fisher,et al.  Groucho-dependent and -independent repression activities of Runt domain proteins , 1997, Molecular and cellular biology.

[79]  D. LeBrun,et al.  Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation. , 2012, Biochimica et biophysica acta.

[80]  M. Greaves,et al.  The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. , 2009, The Journal of clinical investigation.

[81]  Rudolf Grosschedl,et al.  Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. , 2010, Immunity.

[82]  Kevin S. Smith,et al.  Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. , 2003, Molecular cell.

[83]  P. Kastner,et al.  Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice , 2006, Molecular and Cellular Biology.

[84]  S. Briggs,et al.  Biochemical and Phosphoproteomic Analysis of the Helix-Loop-Helix Protein E47 , 2012, Molecular and Cellular Biology.

[85]  W. Alexander,et al.  ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. , 2011, Genes & development.

[86]  Trey Ideker,et al.  A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates the B cell fate , 2010, Nature Immunology.

[87]  M. Sigvardsson,et al.  Structural Determination of Functional Domains in Early B-cell Factor (EBF) Family of Transcription Factors Reveals Similarities to Rel DNA-binding Proteins and a Novel Dimerization Motif* , 2010, The Journal of Biological Chemistry.

[88]  E. Papaemmanuil,et al.  Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia , 2009, Nature Genetics.

[89]  J. Kutok,et al.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. , 2004, Blood.

[90]  Amie Y Lee,et al.  Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis , 2005, Oncogene.

[91]  P. Kastner,et al.  Ikaros controls isotype selection during immunoglobulin class switch recombination , 2009, The Journal of experimental medicine.

[92]  Brian T. Chait,et al.  E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein , 2004, Science.

[93]  B. Kim,et al.  PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia. , 2011, Blood cells, molecules & diseases.

[94]  G. Stein,et al.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes , 2010, Journal of cellular physiology.

[95]  K. Blyth,et al.  Runx1 promotes B-cell survival and lymphoma development. , 2009, Blood cells, molecules & diseases.

[96]  F. Staal,et al.  Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development , 2012, Leukemia.

[97]  B. Göttgens,et al.  The proto-oncogene ERG in megakaryoblastic leukemias. , 2005, Cancer research.

[98]  M. Cleary,et al.  RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription , 2006, Oncogene.

[99]  W. Alexander,et al.  Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. , 2010, Blood.

[100]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[101]  D. Littman,et al.  Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. , 2007, Blood.

[102]  N. Sebire,et al.  ERG is a megakaryocytic oncogene. , 2009, Cancer research.

[103]  D. Pinkel,et al.  E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas , 1997, Molecular and cellular biology.

[104]  M. Sigvardsson,et al.  Inhibition of p300/CBP by Early B-Cell Factor , 2003, Molecular and Cellular Biology.

[105]  M. Busslinger,et al.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors , 2007, Nature.

[106]  A. Emelyanov,et al.  The Interaction of Pax5 (BSAP) with Daxx Can Result in Transcriptional Activation in B Cells* , 2002, The Journal of Biological Chemistry.

[107]  F. Speleman,et al.  PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B‐NHL with complex chromosomal rearrangements , 2005, Genes, chromosomes & cancer.

[108]  J. Hagman,et al.  Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5 , 2009, Proceedings of the National Academy of Sciences.

[109]  H Clevers,et al.  The chromatin remodelling factor Brg‐1 interacts with β‐catenin to promote target gene activation , 2001, The EMBO journal.

[110]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[111]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[112]  A. Perkins,et al.  Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. , 2003, Immunity.

[113]  D. Littman,et al.  Runx1 Protects Hematopoietic Stem/Progenitor Cells from Oncogenic Insult , 2007, Stem cells.

[114]  M. Waterman,et al.  hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin , 2008, Cancer biology & therapy.

[115]  E. Bertolino,et al.  Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5 , 2008, Nature Immunology.

[116]  Kris Vleminckx,et al.  The p300/CBP acetyltransferases function as transcriptional coactivators of β‐catenin in vertebrates , 2000, The EMBO journal.

[117]  Rudolf Grosschedl,et al.  Structure of an Ebf1:DNA complex reveals unusual DNA recognition and structural homology with Rel proteins. , 2010, Genes & development.

[118]  R. Arceci.  Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia , 2010 .

[119]  D. Eberhard,et al.  The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. , 1999, Cancer research.

[120]  F. Prósper,et al.  Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. , 2007, Blood.

[121]  Albert Gutierrez,et al.  LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. , 2010, Blood.

[122]  B. Kee,et al.  Early B Cell Factor Promotes B Lymphopoiesis with Reduced Interleukin 7 Responsiveness in the Absence of E2A , 2004, The Journal of experimental medicine.

[123]  Y. Hayashi,et al.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[124]  J. Aster,et al.  The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. , 2001, Cancer genetics and cytogenetics.

[125]  O. Haas,et al.  The Leukemia-Specific Fusion Gene ETV6/RUNX1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression , 2011, PloS one.

[126]  Sally E. Johnson,et al.  MEKK1 Signaling through p38 Leads to Transcriptional Inactivation of E47 and Repression of Skeletal Myogenesis* , 2004, Journal of Biological Chemistry.

[127]  G. Nucifora,et al.  SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo , 2003, Oncogene.

[128]  A. Veerman,et al.  IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL , 2010, Leukemia.

[129]  N. Wilson,et al.  Gfi1 Expression Is Controlled by Five Distinct Regulatory Regions Spread over 100 Kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 Acting as Upstream Regulators in Early Hematopoietic Cells , 2010, Molecular and Cellular Biology.

[130]  Stephen L. Nutt,et al.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 , 1999, Nature.

[131]  Markus Jaritz,et al.  The B‐cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis , 2012, The EMBO journal.

[132]  K. Tanaka,et al.  The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability , 1996, Molecular and cellular biology.

[133]  M. Zahurak,et al.  TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. , 2002, Cancer research.

[134]  Michael N. Edmonson,et al.  Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2011, Blood.

[135]  Takashi Akasaka,et al.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. , 2009, Blood.

[136]  M. Farrar,et al.  Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia , 2011, The Journal of experimental medicine.

[137]  S. Orkin,et al.  TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. , 2009, Cell stem cell.

[138]  M. Hubank,et al.  The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors , 2011, Leukemia.